Meredith McKean MD, MPH
@MeredithMcKean
Followers
165
Following
361
Statuses
49
Director of Melanoma and Skin Cancer Research and phase 1 investigator at Sarah Cannon Research Institute
Joined June 2021
RT @ErikaHamilton9: Some of us sat down with @FoxNews to recap 2024 and make some cancer predictions for the new year!
0
4
0
RT @VivekSubbiah: ‼️🚨ASCO elections are open! 🗳️ Please vote early & make your vote count. 👉🏼I’m delighted to endorse Dr. @ErikaHamilton9…
0
8
0
RT @ErikaHamilton9: Look who all ran into each other in hall 6 by chance this morning? @SarahCannonDocs @SCRIOncology strong 💪🏼! At a m…
0
4
0
RT @VivekSubbiah: 🚨Hot of the press - Pleased to share our paper 👉🏼just before @esmo #ESMO24 👉🏼⭐️Huge congratulations to our early phase 1…
0
12
0
@ErikaHamilton9 @VivekSubbiah @SarahCannonDocs @SCRIOncology @AIMatMelanoma @IshwariaMD @CureMelanoma @MelanomaReAlli @doctorpemm @PGrivasMDPhD Such a great morning with the team supporting our melanoma patients and melanoma research!
0
0
3
RT @VivekSubbiah: ⭐️☀️🌞Fantastic day & amazing weather in Nashville, TN for a morning walk with the melanoma clinical research #Dreamteam…
0
1
0
RT @VivekSubbiah: ☀️Amazing day for a morning walk to support melanoma research - melanoma 5k walk ! Slip! Slop! Slap! and Wrap! h/t @Amer…
0
2
0
RT @OncLive: Integrating 15-GEP with PRAME expression status into a 4-group prognostic classification system showed prognostic accuracy in…
0
2
0
RT @MRFCureOM: #ASCO24, Suthee Rapisuwon, MD @LombardiCancer reported on a phase II study of adjuvant nivolumab in combination with ipilim…
0
5
0
RT @HTawbi_MD: Our own Prof. Roda Amaria @MDAndersonNews presenting first results of engineered T cell therapy OBX-115, eliminates need f…
0
9
0
RT @SarahCannonDocs: SCRI’s Dr. @MeredithMcKean takes the #ASCO24 stage in the “PD-1-Refractory Advanced Melanoma: How Do We Get to the Fin…
0
2
0
RT @HTawbi_MD: Amazing results of neoadjuvant low-dose ipi+nivo leading to statistically significant improvement in EFS HR (0.32 , p<0.0001…
0
15
0
RT @ErikaHamilton9: So proud of @DavidRSpigel for an excellent presentation of transforming results with consolidation durvalumab in small…
0
5
0
RT @SarahCannonDocs: SCRI’s @DavidRSpigel presented important updates from the ADRIATIC study for limited stage small cell lung cancer. An…
0
6
0
RT @jasonlukemd: Adjuvant #melanoma phase 2 of pembro +/- individualized neoantigen therapy (mRNA-4157/V940; KEYNOTE-942) @TheLancet! Excit…
0
16
0
RT @OncLive: DKN-01 Plus Bevacizumab and Chemotherapy Shows Tolerability, Activity in MSS CRC @meredithpelster @SarahCannonDocs @asco #GI24…
0
4
0
RT @SarahCannonDocs: We are thrilled to announce SCRI Oncology Partners! With this expansion of the SCRI network, we build upon our capabil…
0
7
0